Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.Pageof 3